Hanbo Chen
University of Toronto
RadiologyRetrospective cohort studyPropensity score matchingSABR volatility modelProspective cohort studyAblative caseCochrane LibraryCommon Terminology Criteria for Adverse EventsEsophagusMediastinumEarly lung cancerRadiation therapyMedicineMeta-analysis
2Publications
1H-index
1Citations
Publications 5
Newest
#1Xuguang Chen (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 2
#2Hanbo Chen (U of T: University of Toronto)H-Index: 9
Last. Umberto Ricardi (UNITO: University of Turin)H-Index: 52
view all 12 authors...
Background: Stereotactic body radiotherapy (SBRT) is increasingly used to treat oligometastatic disease (OMD), but the effect of metastasis timing on patient outcomes remains uncertain. Methods: An international database of patients with OMD treated with SBRT was assembled with rigorous quality assurance. Early versus late metastases were defined as those diagnosed ≤24 versus >24 months from the primary tumor. Overall survival (OS), progression-free survival (PFS), and incidences of wide-spread ...
Source
#1Pejman Jabehdar Maralani (U of T: University of Toronto)H-Index: 12
#2Chia-Lin Tseng (U of T: University of Toronto)H-Index: 14
Last. Hua Lu (U of T: University of Toronto)H-Index: 2
view all 21 authors...
Background null There are no established threshold values regarding the degree of growth on imaging when assessing response of spinal metastases treated with stereotactic body radiation therapy (SBRT). null Objective null To determine a magnetic resonance imaging-based minimum detectable difference (MDD) in gross tumor volume (GTV) and its association with 1-yr radiation site-specific (RSS) progression-free survival (PFS). null Methods null GTVs at baseline and first 2 post-SBRT scans (Post1 and...
Source
#5Alexander V. Louie (Sunnybrook Health Sciences Centre)H-Index: 8
Abstract null null Objectives null Stereotactic ablative radiotherapy (SABR) is used to treat inoperable early-stage, node-negative small cell lung cancer (SCLC). We performed a systematic review and meta-analysis of the literature on SABR for T1-2N0M0 SCLC to summarize outcomes including local control (LC), overall survival (OS), recurrence rates, and toxicity. null null null Materials and methods null This study was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic ...
Source
#1Michael C. Tjong (U of T: University of Toronto)H-Index: 3
#2Nauman Malik (U of T: University of Toronto)H-Index: 3
Last. Alexander V. Louie (U of T: University of Toronto)H-Index: 8
view all 10 authors...
Background Stereotactic ablative radiotherapy (SABR) safety and efficacy for mediastinal and hilar lymphadenopathy (MHL) is not yet established, given its potential for toxicity due to the proximity to esophagus and proximal bronchial tree (PBT). This review summarized current reported outcomes of MHL SABR. Methods This systematic review, based on the PRISMA guidelines, was performed using MEDLINE® (PubMed®), EMBASE and Cochrane Library databases from inception until December 2018. Studies repor...
Source
#1Hanbo ChenH-Index: 9
#2S. SenanH-Index: 5
Last. Laba JmH-Index: 1
view all 14 authors...
Close Researchers
Alexander V. Louie
H-index : 8
Sunnybrook Health Sciences Centre
R Gabriel. Boldt
H-index : 1
University of Western Ontario
S. Senan
H-index : 5
London Health Sciences Centre
Christopher Goodman
H-index : 2
University of Western Ontario
R. Gabriel Boldt
H-index : 8
London Health Sciences Centre
Michael C. Tjong
H-index : 4
Princess Margaret Cancer Centre
David Palma
H-index : 3
University of Western Ontario
Yee C Ung
H-index : 7
University of Toronto
Goodman C D
Boldt R Gabriel
Alexander V. Louie
H-index : 29
University of Western Ontario
Hanbo Chen
H-index : 9
Sunnybrook Health Sciences Centre
Joanna Laba
H-index : 6
London Health Sciences Centre
Patrick Cheung
H-index : 29
University of Toronto
David A. Palma
H-index : 55
London Health Sciences Centre
Arjun Sahgal
H-index : 66
Sunnybrook Health Sciences Centre
Suresh Senan
H-index : 86
VU University Medical Center
May Tsao
H-index : 17
University of Toronto
Ian Poon
H-index : 20
Sunnybrook Health Sciences Centre
George J. Li
H-index : 3
University of Toronto
Joanna Laba
Nauman Malik
H-index : 3
University of Toronto
Sunit Das
H-index : 23
University of Toronto
Pascal N. Tyrrell
H-index : 31
University of Toronto
Umberto Ricardi
H-index : 52
University of Turin
Seyedmehdi Payabvash
H-index : 25
Yale University
Matthew Foote
Alexandra Hospital
Hamidreza Baharjoo
University of Toronto
David Y. Mak
H-index : 1
University of Toronto
Z.A. Husain
H-index : 3
Sunnybrook Research Institute
Aimee K.M. Chan
H-index : 1
University of Toronto
Jay Detsky
H-index : 9
Sunnybrook Research Institute
Amir H. Safavi
H-index : 1
Xuguang Chen
H-index : 2
Johns Hopkins University School of Medicine
Sten Myrehaug
H-index : 11
Sunnybrook Research Institute
Hany Soliman
H-index : 17
Sunnybrook Research Institute
Hua Lu
H-index : 2
University of Toronto
Chris Heyn
H-index : 14
University of Toronto
Kristin J. Redmond
H-index : 21
Johns Hopkins University School of Medicine
Tithi Biswas
H-index : 13
Case Western Reserve University
Archya Dasgupta
H-index : 7
Sunnybrook Health Sciences Centre
Peter Howard
H-index : 11
Sunnybrook Health Sciences Centre
Serena Badellino
H-index : 13
University of Turin
Chia-Lin Tseng
H-index : 14
Sunnybrook Health Sciences Centre
Erin Wong
H-index : 13
Sunnybrook Health Sciences Centre
Darby Erler
H-index : 11
Sunnybrook Health Sciences Centre
Pejman Jabehdar Maralani
H-index : 12
Sunnybrook Health Sciences Centre
Sean P. Symons
H-index : 35
University of Toronto
Roi Dagan
H-index : 15
University of Florida
Matthew Foote
H-index : 20
Princess Alexandra Hospital
Anish Kapadia
H-index : 7
University of Toronto
Eshetu G. Atenafu
H-index : 37
University Health Network
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.